Responsibility of scientists to dispel rumors on technologies: DG ICMR

Besides doing science, the researchers should makes sure that there is proper communication with common public and media, feels Dr Soumya Swaminathan, director general, Indian Council for Medical research (ICMR)


"'We need agencies such as Biotechnology Industry Research Assistance Council (BIRAC) and National Research Development (NRDC) to bridge gap between research and laboratories," opined Dr Soumya Swaminathan, DG, ICMR. She was addressing the gathering at the Thomson Reuters Research Excellence - India Citation Awards 2015 presentation event held on September, 18 in New Delhi.

"Political leadership supports scientists. Prime minister has himself advised breaking of silos. He asked us to identify challenges of malnutrition through various programmes including creation of grand challenges. Earlier there used to be lack of coordination between various ministries but now 10-12 ministries that concern science in India, are working closely," mentioned the ICMR chief while talking about government policy.

Dr Swaminathan urged the scientists to communicate more. She said, "Scientists cannot just do science but it is equally their responsibility to spread awareness. They must learn more to communicate with media and general public. Lots of misconceptions about technology and its products are floated from time to time creating a huge wedge between reality and myth. Our responsibility is to put in place the scientific facts and dispel rumors."

The ICMR DG also emphasized on broadening scientific horizons. "The use of space technology and satellites can be used to make differences in lives of people," she concluded.

Dr Swaminathan has recently joined the ICMR as DG and secretary, Department of Health Research (ministry of health and family welfare) with effect from August 17, 2015. She brings with her, the vast experience in health research and research administration. Prior to this assignment, Dr Soumya Swaminathan was director, National Institute for Research in Tuberculosis (NIRT) in Chennai since 2012.

1 Comment Comment 1 - 1 of 1

Pradip Nahar 24 September 2015 at 04:37 PM

We have developed, A Low cost image based next generation ELISA for diagnosis of diseases as a part of affordable health care. Spectrophotometer free image-based -ELISA is cheap, sensitive, specific and rapid, it can be employed in both resource-rich and resource-limited settings either as POC or as a powerful alternative to conventional ELISA. Preamble: Disadvantages of conventional assays, normally performed in a 96-well microtiter or ELISA plate are: (i) 96-well microtiter plate itself is costly, (ii) ELISA reader is a bulky and an expensive instrument which is not easily available in resource-poor areas, and (iii) requires large volumes of costly reagents and analyte. Salient features of our technology: Affordable: The present technology provides a low cost diagnostic tool for the detection of numerous diseases for millions of poor living in resource poor areas where diagnosis is treated as extravagant expenditure unless emergency arises. Sensitive: Better than or comparable to conventional ELISA Specific: No non-specific binding. Better than conventional ELISA User-friendly: Simple-to-use tool. Does not require high expertise Rapid and robust: Take less than 5 minutes (one of the fastest ELISA in the current scenario) compared to 18 h conventional procedure. Equipment free: It does not require costly ELISA reader and microtiter ELISA plate. The present assay system replaces spectrophotometer by a photocolorimeter, common desktop scanner or smart phone. Deliverable: Nanoplate made of polypropylene is much cheaper than whatman paper or other support. Nanoplate can be easily prepared in mass scale. Photocolorimeter can also be prepared easily. This is a world class technology and can compete with globally developed technology having implication in affordable health care, import substitution with export potential. Any taker? Scientist CSIR-IGIB


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email